| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $309.06B | $290.40B | $232.26B | $176.95B | $140.80B |
| Cost of Revenue | $58.79B | $44.52B | $35.77B | $28.45B | $23.66B |
| Gross Profit | $250.28B | $245.88B | $196.50B | $148.51B | $117.14B |
| Operating Expenses | – | – | – | – | – |
| R&D | $52.04B | $48.06B | $32.44B | $24.05B | $17.77B |
| SG&A | $5.97B | $5.28B | $4.86B | $4.47B | $4.05B |
| Operating Income | $127.66B | $128.34B | $102.57B | $74.81B | $58.64B |
| Interest Expense | $6.78B | $7.35B | $845.00M | $5.99B | $2.45B |
| Tax Expense | $28.11B | $26.20B | $20.99B | $13.54B | $11.32B |
| Net Income | $102.43B | $100.99B | $83.68B | $55.52B | $47.76B |
| EPS (basic) | 23.0600 | 22.6700 | 18.6700 | 24.5100 | 20.7900 |
| EPS (diluted) | 23.0300 | 22.6300 | 18.6200 | 24.4400 | 20.7400 |
| Shares (diluted) | $4.45B | $4.46B | $4.49B | $2.27B | $2.30B |